Gangnam Severance Hospital Signs Agreement with Elekta for Patient-Customized Cancer Treatment Education and Research

Gangnam Severance Hospital announced on the 29th that it has signed a Reference Site agreement for the high-resolution magnetic resonance imaging-guided radiation therapy system 'Unity' with the global medical device company Elekta.

Gangnam Severance Hospital and Elekta are taking a commemorative photo after signing a business agreement for personalized cancer treatment and research.
[Photo by Gangnam Severance Hospital]

Through this agreement, both institutions will utilize Elekta Unity clinical experience to ▲conduct on-site visits to domestic and overseas medical institutions for clinical workflow and procedure training ▲mutually support and cooperate in presenting treatment outcomes and research exchanges through online and offline channels.

Selected as a training institution, Gangnam Severance Hospital plans to present and share treatment experiences of various cases using Unity, including prostate cancer, liver tumors, breast cancer, lymph node metastasis, and rectal cancer, at meetings and conferences with experts chosen by Elekta. Elekta will provide the hospital with opportunities to observe how Unity is utilized overseas and offer the latest technical support.

Elekta's Unity is a state-of-the-art radiation cancer treatment system that combines a linear accelerator (Linac), a radiation therapy device, with high-resolution 1.5T magnetic resonance imaging (MRI) technology. It can track the tumor's condition and location in real time to minimize the radiation exposure area and allows immediate correction of radiation therapy plans, providing convenient and precise patient-tailored treatment. Currently, it is installed in 63 hospitals worldwide, and Gangnam Severance Hospital was the first in Korea to introduce it in August 2021.

Hospital Director Song Young-gu said, "Through this agreement, our hospital has gained the opportunity to share the patient-tailored radiation cancer treatment experience and know-how accumulated while operating Unity with experts from around the world," adding, "We hope that effective and precise treatment will be provided to many patients through additional education and research in the future."

This content was produced with the assistance of AI translation services.